Pharmaceutical Commerce - March 2020
Dramatic growth tracks the flood of new specialty pharmaceuticals entering the market
ICER will expand use of RWE, as the Federal ONC calls for broader use of healthcare data
Clarivate Analytics predicts both approvals and commercial potential
A former executive at PhRMA, Davis will now lead the wholesaler-distributor association
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
2
Pharma Pulse: Amgen's Uplizna Secures CD19 Approval for Myasthenia Gravis, as Asthma Biologic Switches Highlight Efficacy Expectations Gap
3
Trade & Channel Strategies 2025: Inside Pharma’s Turning Point
4
Working with the Middle
5
